Seneschal Advisors’s ResMed RMD Stock Holding History

Seneschal Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$449	Hold	2	–	–	﹤0.01%	391
2025 Q4	$482	Hold	2	–	–	﹤0.01%	367
2025 Q3	$548	Buy	+2	New	+$546	﹤0.01%	340

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Seneschal Advisors's RMD Position: Q1 2026 in Review

Seneschal Advisors held its ResMed (RMD) position steady in Q1 2026 at 2 shares worth $449. The position accounts for ﹤0.01% of the portfolio, ranked #391.

Seneschal Advisors first reported a position in RMD in Q3 2025 and has held it in 3 quarters since. The position peaked at $548 in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Seneschal Advisors held 2 shares of ResMed worth $449 as of Q1 2026.
Seneschal Advisors left its ResMed share count unchanged in Q1 2026.
ResMed made up ﹤0.01% of Seneschal Advisors's portfolio in Q1 2026, its #391 holding.
Seneschal Advisors first reported a position in ResMed in Q3 2025 and has held it in 3 quarters since.
Seneschal Advisors's ResMed position peaked at $548 in Q3 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Seneschal Advisors's 13F filing for Q1 2026, filed 8 May 2026.